Cargando…
Low levels of Human Cytomegalovirus Infection in Glioblastoma multiforme associates with patient survival; -a case-control study
BACKGROUND: Glioblastoma multiforme (GBM) represent the most aggressive brain tumor with a median overall survival of about 12-15 months. Over 90% of GBM tumors have recently been shown to be infected with human cytomegalovirus (HCMV). In this case-control study, we evaluated whether there was an as...
Autores principales: | Rahbar, Afsar, Stragliotto, Giuseppe, Orrego, Abiel, Peredo, Inti, Taher, Chato, Willems, Jan, Söderberg-Naucler, Cecilia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348037/ https://www.ncbi.nlm.nih.gov/pubmed/22424569 http://dx.doi.org/10.1186/2042-4280-3-3 |
Ejemplares similares
-
Presence of the Human Cytomegalovirus in Glioblastomas—A Systematic Review
por: Peredo-Harvey, Inti, et al.
Publicado: (2021) -
Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma
por: Stragliotto, Giuseppe, et al.
Publicado: (2020) -
Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma
por: Pantalone, Mattia Russel, et al.
Publicado: (2022) -
Higher Human Cytomegalovirus (HCMV) Specific IgG Antibody Levels in Plasma Samples from Patients with Metastatic Brain Tumors Are Associated with Longer Survival
por: Peredo-Harvey, Inti, et al.
Publicado: (2023) -
High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes
por: Taher, Chato, et al.
Publicado: (2013)